Oporto, Zeironn M.
HRN: 26-27-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/23/2024
11/30/2024
IV
50mg
Q24H
Neonatal Pneumonia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes